Baseman J. B. Interplay between Mycoplasma Surface Proteins, Airway Cells, and the Protean Manifestations of Mycoplasma-mediated Human Infections. American Journal of Respiratory and Critical Care Medicine. 1996, 154: 137–144. doi:10.1164/ajrccm/154.4_Pt_2.S137.
Razin S., Yogev D., Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev. 1998, 62 (4): 1094–156. PMID 9841667.
Kashyap S., Sarkar, M. Mycoplasma pneumonia: Clinical features and management. Lung India. 2010, 27 (2): 75–85. doi:10.4103/0970-2113.63611.
Ferwerda A., Moll H. A., de Groot R. Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr. 2001, 160 (8): 483–491. PMID 11548186.
Esposito S., Droghetti R., Bosis S., Claut L. Marchisio P., Principi N. Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze. Pediatric Pulmonology. 2002, 34 (2): 122–127. doi:10.1002/ppul.10139.
Ríos A. M., Mejías A., Chávez-Bueno S., Fonseca-Aten M., Katz K., Hatfield J., Gómez A. M., Jafri H. S., McCracken G. H., Ramilo O., Hardy R. D. Impact of Cethromycin (ABT-773) Therapy on Microbiological, Histologic, Immunologic, and Respiratory Indices in a Murine Model of Mycoplasma pneumoniae Lower Respiratory Infection. Antimicrob Agents Chemother. 2004, 48 (8): 2897–2904. doi:10.1128/AAC.48.8.2897-2904.2004.